BioSpace News Archive

RQ Bio emerges from stealth mode announcing its launch as a new UK-based biotechnology company following the completion of a successful licensing deal with AstraZeneca for RQ Bio’s existing mAbs against SARS-CoV-2.

Sosei Group Corporation, the international biopharmaceutical company, and New York City-based Kallyope, pioneers in drug discovery involving the gut-brain axis, have entered a strategic research collaboration to identify and validate novel G protein-coupled receptor targets with a goal of creating new drug discovery programs in the area of gastrointestinal diseases.

iOnctura SA, a clinical-stage oncology company targeting key resistance mechanisms in solid tumors, announced that it will present Phase Ib data on its lead pipeline asset, IOA-244, the highly differentiated novel phosphoinositide 3-kinase delta inhibitor, at the 2022 ASCO Annual Meeting, taking place June 3-7 in Chicago.

OBI Pharma, Inc. announced that data highlighting ongoing clinical studies targeting Globo H and AKR1C3 in different tumor types will be presented at the American Society of Clinical Oncology meeting from June 3–7, 2022 in Chicago, IL.

ReCor Medical, Inc. and Otsuka Medical Devices Co., Ltd. a fully owned subsidiary of Otsuka Holdings Co., Ltd., announced that Dr. Ajay Kirtane presented a pooled data analysis from ReCor’s two randomized, sham-controlled trials evaluating the Paradise™ Ultrasound Renal Denervation System for the treatment of hypertension at the EuroPCR annual meeting in Paris.

BeiGene, Ltd., a global biotechnology company focused on developing and commercializing innovative medicines worldwide, yesterday announced the opening of a new regional office in Basel, Switzerland.

DUBAI, United Arab Emirates, In the report published by Future Market Insights titled “Disposable Negative Pressure Wound Therapy Devices Market: Global Industry Analysis and Opportunity Assessment ”, it has been stated that the development around the globe in the last couple of years reflected certain complexities and fissures related to the political environment across many countries.

The rising need for dental repair procedures has led to the increasing popularity of dental compressors.

The global cardiac ablation devices market is expected to grow at a favorable rate from 2021 to 2031.

Albany NY, United States: The rise in adoption of personalized medicine, increasing drug development activities, and technological advancements are all likely to drive expansion of the global protein characterization and identification market.